sb 203580 has been researched along with niacinamide in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (niacinamide) | Trials (niacinamide) | Recent Studies (post-2010) (niacinamide) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 13,381 | 1,097 | 5,797 |
Protein | Taxonomy | sb 203580 (IC50) | niacinamide (IC50) |
---|---|---|---|
Chain A, NAD-dependent deacetylase | Thermotoga maritima | 1000 | |
Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | 3.3 | |
NAD-dependent protein deacetylase sirtuin-2 | Homo sapiens (human) | 2.9 | |
NAD-dependent protein deacetylase sirtuin-3, mitochondrial | Homo sapiens (human) | 8.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Di Sabatino, A; Docena, G; Fanning, A; Knowles, CH; Kruidenier, L; Leakey, NA; Lee, K; MacDonald, TT; McLean, PG; Nally, K; Rovedatti, L; Shanahan, F | 1 |
1 other study(ies) available for sb 203580 and niacinamide
Article | Year |
---|---|
Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease.
Topics: Adolescent; Adult; Blotting, Western; Cells, Cultured; Cytokines; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Female; Humans; Imidazoles; Inflammation Mediators; Inflammatory Bowel Diseases; Interleukin-1beta; Interleukin-6; Intestinal Mucosa; Male; Middle Aged; Niacinamide; Organ Culture Techniques; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Pyrimidines; Tumor Necrosis Factor-alpha; Young Adult | 2010 |